CTO analysis architecture and solutions requirement
Ended Awarded Last action
- Contract number
- 75F40118F10196
- Awardee
-
Datawiz Corporation UEI LTKPTJP8RET1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $3,047,697
Award facts
- Contract value 81% obligated
-
- $3,047,697.00 Current, with exercised options
- $3,740,577.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- 8(a) Sole Source
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $1,015,899 | |
| Other Administrative Action | $0 | |
| Original award | $2,031,798 |
About this award
The Food and Drug Administration awarded an 8(a) sole source delivery order to Datawiz Corporation for CTO Analysis Architecture and Solutions Requirement services, valued at $3.74 million. The contract, awarded on August 22, 2018, with an ultimate completion date of March 20, 2020, was executed under the 8a Streamlined Technology Acquisition Resources for Services (8a STARS II) GWAC. Work will be performed in Silver Spring, Maryland, where the FDA maintains significant operations. Datawiz Corporation, a self-certified small disadvantaged business based in Chantilly, Virginia, specializes in comprehensive information technology services for federal agencies and has been registered in SAM.gov since 2003.
This engagement reflects the FDA's reliance on external technical expertise for enterprise architecture and analysis capabilities supporting Chief Technology Officer functions. Datawiz brings relevant experience from prior federal engagements, particularly with the Department of Health and Human Services and EPA, where the company has demonstrated competency in IT infrastructure, security assessments, enterprise architecture, and program management. The 8(a) sole source designation indicates the agency determined that Datawiz possessed unique qualifications for these specialized CTO-level analytical and architectural services, leveraging the company's established track record in delivering complex technology solutions to federal clients.
Quick answers
Who was awarded contract 75F40118F10196?
75F40118F10196 was awarded to Datawiz Corporation by Food and Drug Administration (Department of Health and Human Services) on August 22, 2018.
How much is contract 75F40118F10196 worth?
The government has obligated $3,047,697 on 75F40118F10196. Its potential value, with all options, is $3,740,577.
Is contract 75F40118F10196 an order under another contract?
Yes. 75F40118F10196 is a delivery order under GS06F0931Z, a government wide acquisition contract (GWAC), on 8a Streamlined Technology Acquisition Resources for Services (8a STARS II).
Was contract 75F40118F10196 competed?
The extent of competition for 75F40118F10196 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: 8(a) Sole Source.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award